Cervical HR-HPV infection
Conditions
Sponsors
Guangdong Provincial Hospital of Traditional Chinese Medicine
Eligibility
Sex/Gender
Female
Age
21 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1. HPV high-risk type positive; 2. The pathological diagnosis is LSIL and below (including chronic mucosal inflammation, subclinical infection); 3. HR-HPV infection >=6 months; 4. The patient is willing to cooperate with the treatment follow-up and sign the informed consent form; 5. Researchers believe that patients are suitable for participating in clinical trials; 6. The patient did not participate in clinical trials of other drugs, and did not use drugs with similar therapeutic effects as the trial drugs; 7. Female patients between 21-65 years old, regular menstruation or menopause, with a history of sexual life.
Exclusion criteria
Exclusion criteria: 1. Acute infection of the external genital area; 2. Lactating women, pregnant women; 3. Patients with systemic chronic wasting disease, severe cardiovascular, liver and kidney disease, hematopoietic system disease; 4. Patients with mental illness; 5. History of drug allergy or allergy; 6. Those who have recently had a birth request; 7. Pathological diagnosis of HSIL.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pathological reversal rate;HPV negative rate; | — |
Countries
China
Contacts
Public ContactXiao Jing
Guangzhou University of Chinese Medicine
Outcome results
None listed